[Antiandrogen withdrawal syndrome in hormone refractory metastatic prostate cancer]

Rev Med Interne. 1997;18(9):732-4. doi: 10.1016/s0248-8663(97)83757-5.

[Article in French]

Authors

G Coutant, J P Algayres, M L Dordain, F Selle, P Y Le Berruyer, H Bili, J P Daly

PMID: 9365728
DOI: 10.1016/s0248-8663(97)83757-5

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / drug therapy
Adenocarcinoma / pathology*
Adenocarcinoma / secondary
Aged
Androgen Antagonists / adverse effects*
Bone Neoplasms / drug therapy
Bone Neoplasms / pathology
Bone Neoplasms / secondary*
Humans
Male
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / blood
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / pathology
Substance Withdrawal Syndrome*

Substances

Androgen Antagonists
Prostate-Specific Antigen